Vanguard Group’s Eli Lilly LLY Stock Holding History

Vanguard Group’s Portfolio LLY Stock Details LLY Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$62.7B	Buy	80,407,430 +1,183,038	+1%	+$922M	1.01%	12
2025 Q1	$65.4B	Buy	79,224,392 +4,975,395	+7%	+$4.11B	1.18%	10
2024 Q4	$57.3B	Buy	74,248,997 +475,530	+0.6%	+$367M	1%	12
2024 Q3	$65.4B	Sell	73,773,467 -85,541	-0.1%	-$75.8M	1.17%	10
2024 Q2	$66.9B	Buy	73,859,008 +1,113,997	+2%	+$1.01B	1.28%	9
2024 Q1	$56.6B	Buy	72,745,011 +1,133,810	+2%	+$882M	1.12%	10
2023 Q4	$41.7B	Buy	71,611,201 +1,035,599	+1%	+$604M	0.91%	13
2023 Q3	$37.9B	Buy	70,575,602 +659,838	+0.9%	+$354M	0.93%	13
2023 Q2	$32.8B	Sell	69,915,764 -81,618	-0.1%	-$38.3M	0.78%	17
2023 Q1	$24B	Sell	69,997,382 -3,432,481	-5%	-$1.18B	0.61%	22
2022 Q4	$26.9B	Buy	73,429,863 +841,546	+1%	+$308M	0.73%	17
2022 Q3	$23.5B	Buy	72,588,317 +996,990	+1%	+$322M	0.69%	17
2022 Q2	$23.2B	Buy	71,591,327 +1,110,149	+2%	+$360M	0.65%	21
2022 Q1	$20.2B	Buy	70,481,178 +1,219,424	+2%	+$349M	0.48%	27
2021 Q4	$19.1B	Buy	69,261,754 +218,594	+0.3%	+$60.4M	0.43%	35
2021 Q3	$16B	Buy	69,043,160 +73,612	+0.1%	+$17M	0.4%	39
2021 Q2	$15.8B	Sell	68,969,548 -317,415	-0.5%	-$72.9M	0.39%	41
2021 Q1	$12.9B	Buy	69,286,963 +625,469	+0.9%	+$117M	0.35%	48
2020 Q4	$11.6B	Sell	68,661,494 -503,870	-0.7%	-$85.1M	0.34%	51
2020 Q3	$10.2B	Sell	69,165,364 -2,439,723	-3%	-$361M	0.34%	56
2020 Q2	$11.8B	Sell	71,605,087 -1,070,561	-1%	-$176M	0.42%	41
2020 Q1	$10.1B	Buy	72,675,648 +1,755,598	+2%	+$244M	0.43%	40
2019 Q4	$9.32B	Sell	70,920,050 -45,200	-0.1%	-$5.94M	0.32%	58
2019 Q3	$7.94B	Sell	70,965,250 -169,128	-0.2%	-$18.9M	0.29%	61
2019 Q2	$7.88B	Buy	71,134,378 +578,045	+0.8%	+$64M	0.3%	57
2019 Q1	$9.16B	Sell	70,556,333 -5,101,886	-7%	-$662M	0.36%	48
2018 Q4	$8.76B	Buy	75,658,219 +1,525,234	+2%	+$177M	0.39%	41
2018 Q3	$7.96B	Buy	74,132,985 +511,752	+0.7%	+$54.9M	0.31%	57
2018 Q2	$6.28B	Buy	73,621,233 +585,843	+0.8%	+$50M	0.26%	66
2018 Q1	$5.65B	Buy	73,035,390 +812,993	+1%	+$62.9M	0.25%	69
2017 Q4	$6.1B	Buy	72,222,397 +917,021	+1%	+$77.5M	0.27%	61
2017 Q3	$6.1B	Buy	71,305,376 +1,097,485	+2%	+$93.9M	0.29%	58
2017 Q2	$5.78B	Buy	70,207,891 +1,610,885	+2%	+$133M	0.28%	58
2017 Q1	$5.77B	Buy	68,597,006 +2,181,701	+3%	+$184M	0.3%	54
2016 Q4	$4.88B	Buy	66,415,305 +1,470,123	+2%	+$108M	0.27%	61
2016 Q3	$5.21B	Buy	64,945,182 +1,708,505	+3%	+$137M	0.31%	52
2016 Q2	$4.98B	Buy	63,236,677 +1,350,329	+2%	+$106M	0.31%	53
2016 Q1	$4.46B	Buy	61,886,348 +1,973,169	+3%	+$142M	0.29%	60
2015 Q4	$5.05B	Buy	59,913,179 +1,552,428	+3%	+$131M	0.34%	51
2015 Q3	$4.88B	Buy	58,360,751 +892,283	+2%	+$74.7M	0.35%	50
2015 Q2	$4.8B	Buy	57,468,468 +697,084	+1%	+$58.2M	0.32%	51
2015 Q1	$4.12B	Buy	56,771,384 +2,042,825	+4%	+$148M	0.28%	61
2014 Q4	$3.78B	Buy	54,728,559 +1,731,599	+3%	+$119M	0.27%	65
2014 Q3	$3.44B	Buy	52,996,960 +1,036,766	+2%	+$67.2M	0.27%	64
2014 Q2	$3.23B	Buy	51,960,194 +778,619	+2%	+$48.4M	0.25%	67
2014 Q1	$3.01B	Buy	51,181,575 +1,056,459	+2%	+$62.2M	0.25%	71
2013 Q4	$2.56B	Buy	50,125,116 +719,465	+1%	+$36.7M	0.22%	81
2013 Q3	$2.49B	Buy	49,405,651 +1,065,947	+2%	+$53.6M	0.24%	77
2013 Q2	$2.37B	Buy	+48,339,704	New	+$2.37B	0.25%	71